148 related articles for article (PubMed ID: 16242125)
1. Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines.
Puttaparthi K; Elliott JL
Exp Neurol; 2005 Dec; 196(2):441-51. PubMed ID: 16242125
[TBL] [Abstract][Full Text] [Related]
2. Assessing the role of immuno-proteasomes in a mouse model of familial ALS.
Puttaparthi K; Van Kaer L; Elliott JL
Exp Neurol; 2007 Jul; 206(1):53-8. PubMed ID: 17482163
[TBL] [Abstract][Full Text] [Related]
3. Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes.
Puttaparthi K; Wojcik C; Rajendran B; DeMartino GN; Elliott JL
J Neurochem; 2003 Nov; 87(4):851-60. PubMed ID: 14622116
[TBL] [Abstract][Full Text] [Related]
4. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
5. Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts.
Turner BJ; Lopes EC; Cheema SS
J Cell Biochem; 2004 Apr; 91(5):1074-84. PubMed ID: 15034941
[TBL] [Abstract][Full Text] [Related]
6. Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis.
Cheroni C; Marino M; Tortarolo M; Veglianese P; De Biasi S; Fontana E; Zuccarello LV; Maynard CJ; Dantuma NP; Bendotti C
Hum Mol Genet; 2009 Jan; 18(1):82-96. PubMed ID: 18826962
[TBL] [Abstract][Full Text] [Related]
7. Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis.
Kabashi E; Agar JN; Taylor DM; Minotti S; Durham HD
J Neurochem; 2004 Jun; 89(6):1325-35. PubMed ID: 15189335
[TBL] [Abstract][Full Text] [Related]
8. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis.
Elliott JL
Brain Res Mol Brain Res; 2001 Nov; 95(1-2):172-8. PubMed ID: 11687290
[TBL] [Abstract][Full Text] [Related]
9. Proteasomes remain intact, but show early focal alteration in their composition in a mouse model of amyotrophic lateral sclerosis.
Kabashi E; Agar JN; Hong Y; Taylor DM; Minotti S; Figlewicz DA; Durham HD
J Neurochem; 2008 Jun; 105(6):2353-66. PubMed ID: 18315558
[TBL] [Abstract][Full Text] [Related]
10. Impaired proteasome function in sporadic amyotrophic lateral sclerosis.
Kabashi E; Agar JN; Strong MJ; Durham HD
Amyotroph Lateral Scler; 2012 Jun; 13(4):367-71. PubMed ID: 22632443
[TBL] [Abstract][Full Text] [Related]
11. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Hensley K; Floyd RA; Gordon B; Mou S; Pye QN; Stewart C; West M; Williamson K
J Neurochem; 2002 Jul; 82(2):365-74. PubMed ID: 12124437
[TBL] [Abstract][Full Text] [Related]
12. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
Wang R; Zhang D
Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis.
Ahtoniemi T; Goldsteins G; Keksa-Goldsteine V; Malm T; Kanninen K; Salminen A; Koistinaho J
Mol Pharmacol; 2007 Jan; 71(1):30-7. PubMed ID: 17008387
[TBL] [Abstract][Full Text] [Related]
14. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
15. Selective formation of certain advanced glycation end products in spinal cord astrocytes of humans and mice with superoxide dismutase-1 mutation.
Shibata N; Hirano A; Hedley-Whyte ET; Dal Canto MC; Nagai R; Uchida K; Horiuchi S; Kawaguchi M; Yamamoto T; Kobayashi M
Acta Neuropathol; 2002 Aug; 104(2):171-8. PubMed ID: 12111360
[TBL] [Abstract][Full Text] [Related]
16. Alteration of familial ALS-linked mutant SOD1 solubility with disease progression: its modulation by the proteasome and Hsp70.
Koyama S; Arawaka S; Chang-Hong R; Wada M; Kawanami T; Kurita K; Kato M; Nagai M; Aoki M; Itoyama Y; Sobue G; Chan PH; Kato T
Biochem Biophys Res Commun; 2006 May; 343(3):719-30. PubMed ID: 16563356
[TBL] [Abstract][Full Text] [Related]
17. In vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOD1/G93A(+) mouse model of amyotrophic lateral sclerosis.
Milanese M; Zappettini S; Jacchetti E; Bonifacino T; Cervetto C; Usai C; Bonanno G
J Neurochem; 2010 Apr; 113(2):489-501. PubMed ID: 20132478
[TBL] [Abstract][Full Text] [Related]
18. Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis.
Hensley K; Fedynyshyn J; Ferrell S; Floyd RA; Gordon B; Grammas P; Hamdheydari L; Mhatre M; Mou S; Pye QN; Stewart C; West M; West S; Williamson KS
Neurobiol Dis; 2003 Oct; 14(1):74-80. PubMed ID: 13678668
[TBL] [Abstract][Full Text] [Related]
19. CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70.
Urushitani M; Kurisu J; Tateno M; Hatakeyama S; Nakayama K; Kato S; Takahashi R
J Neurochem; 2004 Jul; 90(1):231-44. PubMed ID: 15198682
[TBL] [Abstract][Full Text] [Related]
20. Elevation of the Hsp70 chaperone does not effect toxicity in mouse models of familial amyotrophic lateral sclerosis.
Liu J; Shinobu LA; Ward CM; Young D; Cleveland DW
J Neurochem; 2005 May; 93(4):875-82. PubMed ID: 15857390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
